185962-07-6

Basic information

• Product Name: 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one
• Synonyms: 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one;1,3-dihydro-1-(4-piperidinyl)-2H-Imidazo[4,5-c]pyridin-2-one
• CAS NO: 185962-07-6
• Molecular Formula: C11H14N4O
• Molecular Weight: 218.25506
• Mol File: 185962-07-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one(185962-07-6)
• EPA Substance Registry System: 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one(185962-07-6)

Safety Data

• Hazardous Substances Data: 185962-07-6(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 12 carbon (C) atoms, 15 hydrogen (H) atoms, 3 nitrogen (N) atoms, and 1 oxygen (O) atom.

Explanation

A heterocyclic compound is a cyclic compound containing atoms of at least two different elements. In this case, the compound contains carbon, hydrogen, nitrogen, and oxygen atoms, making it a heterocyclic compound.

Explanation

The compound's structure consists of two fused heterocyclic rings a piperidine ring (a six-membered nitrogen-containing ring) and an imidazopyridine ring (a fused five-membered imidazole ring and a six-membered pyridine ring).

Explanation

The compound has been studied for its effects on the central nervous system, specifically for its potential as an analgesic (pain-relieving) and anxiolytic (anxiety-reducing) agent.

Explanation

The compound has been researched for its potential impact on the central nervous system, which is responsible for controlling various functions, including pain perception and emotional regulation.

Explanation

Due to its unique structure and potential pharmacological properties, 1-(piperidin-4-yl)-1H-imidazo[4,5-c]pyridin-2(3H)-one is an interesting target for further research and development within the field of medicinal chemistry.

Explanation

Given its potential pharmaceutical applications and the need for new treatments in pain management and anxiety disorders, further research and development of this compound is recommended to explore its full potential and optimize its properties for therapeutic use.

Heterocyclic Compound

Yes

Structural Features

Contains a piperidine ring and an imidazopyridine ring

Potential Pharmaceutical Applications

Analgesic and anxiolytic agent

Central Nervous System (CNS) Effects

Investigated for its effects

Field of Interest

Medicinal Chemistry

Further Research and Development

Recommended

Upstream product

• 784155-36-8 ethyl 4-(2-oxo-2,3-dihydro-1H-imidazol[4,5-c]pyridin-1-yl)piperidine-1-carboxylate 
• 58859-46-4 ethyl 4-aminopiperidine-1-carboxylate 
• 183283-22-9 ethyl 4-[(3-aminopyridin-4-yl)amino]piperidine-1-carboxylate 
• 183283-21-8 ethyl 4-[(3-nitropyridin-4-yl)amino]piperidine-1-carboxylate 
• 1067718-07-3 tert-butyl 4-((3-nitropyridin-4-yl)amino)piperidine-1-carboxylate 
• 13091-23-1 4-chloro-3-nitropyridine 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 1067718-08-4 tert-butyl 4-((3-aminopyridin-4-yl)amino)piperidine-1-carboxylate 
• 1222161-99-0 tert-butyl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)piperidine-1-carboxylate 

Relevant articles and documents

RESPIRATORY SYNCYTIAL VIRUS INHIBITORS

Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A or CR1BR1B; one of Z2 and Z3 is CH or CR1A', the other is N, CH or CR1A'; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A', R1B, R2 and R3 are as defined herein, their use as inhibitors of RSV and related aspects.

Dipeptides which promote release of growth hormone

Compounds of formula (I) are growth hormone releasing peptide mimetics which are useful for the treatment and prevention of osteoporosis. STR1